Accounts Receivable, Credit Loss Expense (Reversal)
Medtronic Accounts Receivable, Credit Loss Expense (Reversal) increased by 3.7% to $28.00M in Q2 2025 compared to the prior quarter. Year-over-year, this metric grew by 55.6%, from $18.00M to $28.00M. Over 4 years (FY 2021 to FY 2025), Accounts Receivable, Credit Loss Expense (Reversal) shows relatively stable performance with a -1.6% CAGR. This increase may warrant attention — for this metric, lower values are generally preferred.
Analysis
How to read this metric
An increase may signal deteriorating customer credit health or a more aggressive sales strategy targeting riskier clients.
Detailed definition
This represents the estimated expense for accounts receivable that the company believes will not be collected. It serves...
Peer comparison
Standard metric for any business extending credit terms to customers.
operating_provision_for_doubtful_accountsHistorical Data
| Q4 '21 | Q1 '22 | Q2 '22 | Q3 '22 | Q4 '22 | Q1 '23 | Q2 '23 | Q3 '23 | Q4 '23 | Q1 '24 | Q2 '24 | Q3 '24 | Q4 '24 | Q1 '25 | Q2 '25 | Q3 '25 | Q4 '25 | Q1 '26 | |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Value | $25.00M | $15.00M | $26.00M | $8.00M | $9.00M | $15.00M | $22.00M | $17.00M | $19.00M | $21.00M | $24.00M | $17.00M | $28.00M | $18.00M | $48.00M | $30.00M | $27.00M | $28.00M |
| QoQ Change | — | -40.0% | +73.3% | -69.2% | +12.5% | +66.7% | +46.7% | -22.7% | +11.8% | +10.5% | +14.3% | -29.2% | +64.7% | -35.7% | +166.7% | -37.5% | -10.0% | +3.7% |
| YoY Change | — | — | — | — | -64.0% | +0.0% | -15.4% | +112.5% | +111.1% | +40.0% | +9.1% | +0.0% | +47.4% | -14.3% | +100.0% | +76.5% | -3.6% | +55.6% |
Accounts Receivable, Credit Loss Expense (Reversal) at Other Companies
Frequently Asked Questions
- What is Medtronic's accounts receivable, credit loss expense (reversal)?
- Medtronic (MDT) reported accounts receivable, credit loss expense (reversal) of $28.00M in Q2 2025.
- How has Medtronic's accounts receivable, credit loss expense (reversal) changed year-over-year?
- Medtronic's accounts receivable, credit loss expense (reversal) increased by 55.6% year-over-year, from $18.00M to $28.00M.
- What is the long-term trend for Medtronic's accounts receivable, credit loss expense (reversal)?
- Over 4 years (2021 to 2025), Medtronic's accounts receivable, credit loss expense (reversal) has grown at a -1.6% compound annual growth rate (CAGR), from $131.00M to $123.00M.
- What does accounts receivable, credit loss expense (reversal) mean?
- The estimated cost of customers failing to pay their invoices.